Evidence map›Paper›PMID 27141940›Full record

ReviewCellular and molecular life sciences : CMLS2016

Mesenchymal stem cell subpopulations: phenotype, property and therapeutic potential.

Miaohua Mo, Shan Wang, Ying Zhou, Hong Li, Yaojiong Wu

Abstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Evaluation of mesenchymal stem cells as anFrontiers in cell and developmental biology · 2024
    Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Exosomes from CD133Journal of orthopaedic translation · 2023
    Article
  20. Dissecting Heterogeneity Reveals a Unique BAMBIAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Miaohua MoSchool of Life Sciences, Tsinghua University, Beijing, China.
Shan WangSchool of Life Sciences, Tsinghua University, Beijing, China.
Ying ZhouSchool of Life Sciences, Tsinghua University, Beijing, China.
Hong LiDepartment of General Surgery, Qingdao Municipal Hospital, 5 Donghai M Rd, Qingdao, China. qdlidaye@163.com.
Yaojiong WuThe Shenzhen Key Laboratory of Health Sciences and Technology, Graduate School at Shenzhen, Tsinghua University, L406A, Tsinghua Campus, The University Town, Shenzhen, China. wu.yaojiong@sz.tsinghua.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mesenchymal stem cells (MSC) are capable of differentiating into cells of multiple cell lineages and have potent paracrine effects. Due to their easy preparation and low immunogenicity, MSC have emerged as an extremely promising therapeutic agent in regenerative medicine for diverse diseases. However, MSC are heterogeneous with respect to phenotype and function in current isolation and cultivation regimes, which often lead to incomparable experimental results. In addition, there may be specific stem cell subpopulations with definite differentiation capacity toward certain lineages in addition to stem cells with multi-differentiation potential. Recent studies have identified several subsets of MSC which exhibit distinct features and biological activities, and enhanced therapeutic potentials for certain diseases. In this review, we give an overview of these subsets for their phenotypic, biological and functional properties.

Indexed as

Antigens, SurfaceCD146 AntigenCell DifferentiationEndoglinHumansMesenchymal Stem CellsNerve Tissue ProteinsNestinPhenotypeReceptors, CXCR4Receptors, Nerve Growth FactorReceptors, Platelet-Derived Growth FactorRegenerative MedicineVascular Cell Adhesion Molecule-1Antigens, SurfaceCD146 AntigenCXCR4 protein, humanEndoglinENG protein, humanNerve Tissue ProteinsNestinNGFR protein, humanReceptors, CXCR4Receptors, Nerve Growth FactorReceptors, Platelet-Derived Growth FactorSTRO-1 antigen, humanVascular Cell Adhesion Molecule-1CD146Cell surface markersHeterogeneityPDGFRStromal cells

Identifiers

PMID27141940
PMCPMC11108490

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.